Associated Papers
Cyclin-dependent kinase 4 upregulation mediates acquired resistance of dabrafenib plus trametinib in BRAF V600E-mutated lung cancer.
Hirai N et al.
Translational Lung Cancer Research, 2021
34733624 (PubMed )
Supplement: tlcr-10-09-3737-supplementary.pdf
Select a paper to view details